Market revenue in 2023 | USD 7.6 million |
Market revenue in 2030 | USD 15.8 million |
Growth rate | 11% (CAGR from 2023 to 2030) |
Largest segment | Dual channel |
Fastest growing segment | Single Channel |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Single Channel, Dual Channel |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Nexstim Oyj Registered Shs Reg S, LivaNova PLC, NeuroPace Inc |
Dual channel was the largest segment with a revenue share of 57.89% in 2023. Horizon Databook has segmented the Iran deep brain stimulation devices market based on single channel, dual channel covering the revenue growth of each sub-segment from 2018 to 2030.
Among Middle East and African countries, Iran is ranked 15th on the basis of its large youth population, long-term investment potential, healthcare reforms, developing healthcare infrastructure, and potential growth in healthcare & medical devices sector.
Moreover, medical tourism in Iran is growing as the country offers quality expertise at lower cost. These are some of the important factors fueling the growth of the market. In 2014, the first successful deep brain stimulation surgery was performed at Shiraz University of Medical Sciences on a patient diagnosed with Dystonia.
Following this successful surgery, two more surgeries were performed on patients suffering from PD and tremors. Thus, technological advancements, growing awareness about treatments, presence of well-equipped infrastructure are driving growth of the market in Iran.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account